3-Methyl-1,4-dioxo-1,4-dihydro­naphthalen-2-yl 4-amino­benzoate

The crystal structure of the title compound, C(18)H(13)NO(4), the oxidized form of the drug aminaftone used in venous disease therapy, is characterized by the presence of ribbons of hydrogen-bonded mol­ecules parallel to the [111] crystallographic direction and by stacking inter­actions between ring...

Descripción completa

Detalles Bibliográficos
Autores principales: Bambagiotti-Alberti, Massimo, Bartolucci, Gianluca, Bruni, Bruno, Coran, Silvia, Di Vaira, Massimo
Formato: Texto
Lenguaje:English
Publicado: International Union of Crystallography 2008
Materias:
Organic Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2961024/
https://www.ncbi.nlm.nih.gov/pubmed/21202108
http://dx.doi.org/10.1107/S1600536808005308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2961024/
https://www.ncbi.nlm.nih.gov/pubmed/21202108
http://dx.doi.org/10.1107/S1600536808005308

Ejemplares similares